385 filings
Page 16 of 20
8-K
rd7fys3df7i
8 Apr 14
Alkermes Announces Positive Topline Results from Pivotal Phase 3 Study of Aripiprazole Lauroxil for Treatment of Schizophrenia
12:00am
CORRESP
lvyc crhma
3 Apr 14
Correspondence with SEC
12:00am
UPLOAD
0rdlajf
1 Apr 14
Letter from SEC
12:00am
8-K
n8qp0835y5vo 1fp2
27 Feb 14
Results of Operations and Financial Condition
12:00am
10-KT
r6y1t6xx t6w
27 Feb 14
Annual report (with FYE transition)
12:00am
8-K
2mzyh25 vddrwwspgonm
16 Jan 14
Other Events
12:00am
424B5
u7co5
13 Jan 14
Prospectus supplement for primary offering
12:00am
FWP
exo2wde
13 Jan 14
Free writing prospectus
12:00am
8-K
onvwoki
13 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
axuh4qg3
8 Jan 14
Alkermes Announces Advances with Its Late-stage CNS Pipeline
12:00am
8-K
hatxpb2v 3i6y9vaee2
6 Jan 14
Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis
12:00am
8-K
0dhdjeagp gap
9 Dec 13
Departure of Directors or Certain Officers
12:00am
S-3ASR
xwt58xllar 3af
12 Nov 13
Automatic shelf registration
12:00am
8-K
2o220nrvzo9x9
12 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
4mda snahneryg8arj
31 Oct 13
Results of Operations and Financial Condition
12:00am
CT ORDER
fds12t a2q2
9 Aug 13
Confidential treatment order
12:00am
8-K
308 s5vd06bh37b6b
1 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
nvzw veydjmw1g5a4m
25 Jul 13
Results of Operations and Financial Condition
12:00am